NOVAVAX COVID-19 VACCINE, ADJUVANTED: payments to doctors
Payments that named NOVAVAX COVID-19 VACCINE, ADJUVANTED as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $484K
- Providers
- 303
- Transactions
- 502
- Average per transaction
- $964
The per-transaction average — $964 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 303 providers the average total is $1,597, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Novavax Inc | $483,748 | 100.0% |